Eva Compérat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Eva Compérat has a total of 159 co-authors. Here are the top co-authors by number of shared publications:
P. Camparo
Laboratoire d’anatomie pathologique, 80000 Amiens, France
6 shared publications- Olivier Cussenot
Universitätsklinik für Urologie, Medical University Vienna, Vienna, Austria; Centre de Recherche sur les Pathologies Prostatiques, Paris, France
5 shared publications - Pierre Mozer
Academic Department of Urology, Hôpital Pitié-Salpêtrière, AP-HP, UPMC University Paris 06, 75013 Paris, France
5 shared publications M. Rouprêt
4 shared publicationsPhilippe Camparo
Département d'Anatomie Pathologique et d'Epidemiologie et de Santé Publique Nord, Hǒpital Val-de Grǎce, Université Pierre et Marie Curie, ParisVI, Paris, France
4 shared publications- Pierre Bedossa
The LIVERPAT and University of Paris, Paris, France
4 shared publications
Latest Publications
- 1 May 2017
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 98 (5) , 423-428
Comparison of semi-automated and manual methods to measure the volume of prostate cancer on magnetic resonance imaging
- 1 May 2017
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 98 (5) , 423-428
Comparison of semi-automated and manual methods to measure the volume of prostate cancer on magnetic resonance imaging
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , e1056-e1056a
1056 Detection of FGFR3 mutations from urine sediment DNA to predict the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , e1056-e1056a
1056 Detection of FGFR3 mutations from urine sediment DNA to predict the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , e316-e316a
316 Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , e316-e316a
316 Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy
- 20 February 2015
- Published by Springer Nature in Virchows Archiv
- Vol. 466 (5) , 589-594
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old
Urothelial bladder cancer (UBC) is rare in young patients and as a result little information as to tumor type and clinical course are available. We present clinicopathological data of a large series of patients less than 40 years with bladder carcinoma. We included in this retrospective study covering the period from 1992 to 2013 patients less than 40 years with a first diagnosis of bladder cancer. Lesions were classified according to the WHO 2004 classification by uropathologists of ten centers. Stage, grade, multifocality, smoking habits, recurrence, and survival were studied. The cohort comprised of 152 patients, 113 males and 39 females with a mean age of 33.2 years. The large majority of the patients (142) was diagnosed with an urothelial carcinoma, the ten others with various histopathological diagnoses. In the age group less than 30 years old, 40.3 % of the cases concerned a papillary urothelial neoplasia of low malignant potential (PUNLMP). In the age group over 30 years, the proportion of PUNLMP decreased to 27.2 %. Only 5.6 % of the UBC was associated with carcinoma in situ. In 14.1 %, a high grade muscle invasive UC was found; 7.0 % had lymph node and 4.9 % distant metastasis at time of presentation. Four patients presented with a history of schistosomiasis; all had an infiltrating carcinoma. After initial resection, 36 patients relapsed, 17 % as PUNLMP, 53 % as pTa low grade, and 30 % as pTa-pT2 high grade UC. During follow-up, 6 % of the patients died. PUNLMP is the most frequent entity in this patient group. It is important that the PUNLMP entity is maintained in future classification systems.
- 20 February 2015
- Published by Springer Nature in Virchows Archiv
- Vol. 466 (5) , 589-594
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old
Urothelial bladder cancer (UBC) is rare in young patients and as a result little information as to tumor type and clinical course are available. We present clinicopathological data of a large series of patients less than 40 years with bladder carcinoma. We included in this retrospective study covering the period from 1992 to 2013 patients less than 40 years with a first diagnosis of bladder cancer. Lesions were classified according to the WHO 2004 classification by uropathologists of ten centers. Stage, grade, multifocality, smoking habits, recurrence, and survival were studied. The cohort comprised of 152 patients, 113 males and 39 females with a mean age of 33.2 years. The large majority of the patients (142) was diagnosed with an urothelial carcinoma, the ten others with various histopathological diagnoses. In the age group less than 30 years old, 40.3 % of the cases concerned a papillary urothelial neoplasia of low malignant potential (PUNLMP). In the age group over 30 years, the proportion of PUNLMP decreased to 27.2 %. Only 5.6 % of the UBC was associated with carcinoma in situ. In 14.1 %, a high grade muscle invasive UC was found; 7.0 % had lymph node and 4.9 % distant metastasis at time of presentation. Four patients presented with a history of schistosomiasis; all had an infiltrating carcinoma. After initial resection, 36 patients relapsed, 17 % as PUNLMP, 53 % as pTa low grade, and 30 % as pTa-pT2 high grade UC. During follow-up, 6 % of the patients died. PUNLMP is the most frequent entity in this patient group. It is important that the PUNLMP entity is maintained in future classification systems.
- 1 December 2014
- Published by Elsevier in Annales de Pathologie
- Vol. 34 (6) , 448-461
Les tumeurs rénales : recommandations de la conférence de consensus de l’International Society of Urologic Pathology (ISUP) 2012
- 1 December 2014
- Published by Elsevier in Annales de Pathologie
- Vol. 34 (6) , 448-461
Les tumeurs rénales : recommandations de la conférence de consensus de l’International Society of Urologic Pathology (ISUP) 2012
- 16 January 2013
- Published by Elsevier in Progrès en Urologie
- Vol. 23 (3) , 171-175
Le carcinome urothélial des patients de moins de 40ans. Revue du comité de cancérologie de l’Association française d’urologie
- 16 January 2013
- Published by Elsevier in Progrès en Urologie
- Vol. 23 (3) , 171-175
Le carcinome urothélial des patients de moins de 40ans. Revue du comité de cancérologie de l’Association française d’urologie
- 1 April 2012
- Published by Elsevier in Journal de Radiologie Diagnostique et Interventionnelle
- Vol. 93 (4) , 243-253
Classification histologique des tumeurs malignes du rein à l’heure des (r)évolutions diagnostiques et thérapeutiques
- 1 April 2012
- Published by Elsevier in Journal de Radiologie Diagnostique et Interventionnelle
- Vol. 93 (4) , 243-253
Classification histologique des tumeurs malignes du rein à l’heure des (r)évolutions diagnostiques et thérapeutiques
- 29 February 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (1) , e794-e794a
794 Comparison between systematic and MRI targeted prostate biopsy for patients with no history of prostate cancer attending a first round of trans-rectal ultrasound biopsy procedure
- 29 February 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (1) , e794-e794a
794 Comparison between systematic and MRI targeted prostate biopsy for patients with no history of prostate cancer attending a first round of trans-rectal ultrasound biopsy procedure